Acquisition of additional mutations drives accelerated progression of NPM1 positive CMML to AML
Acquisition of additional mutations drives accelerated progression of NPM1 positive CMML to AML
- 20/06/2016
- 10 samples
- DAC: EGAC00001000205
- Technology: Illumina MiSeq
Wellcome Trust Sanger Institute Data Sharing Policy
Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.
| Study ID | Study Title | Study Type |
|---|---|---|
| EGAS00001000619 | Resequencing |
This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.
| ID | File Type | Size | Quality Report |
Located in
i
|
|---|---|---|---|---|
| EGAF00000485383 | cram | 261.6 MB | Report |
|
| EGAF00000485384 | cram | 268.8 MB | Report |
|
| EGAF00000485385 | cram | 210.5 MB | Report |
|
| EGAF00000485386 | cram | 232.5 MB | Report |
|
| EGAF00000485387 | cram | 216.9 MB | Report |
|
| EGAF00000485388 | cram | 236.5 MB | Report |
|
| EGAF00000485389 | cram | 205.6 MB | Report |
|
| EGAF00000485390 | cram | 234.2 MB | Report |
|
| EGAF00000485391 | cram | 248.8 MB | Report |
|
| EGAF00000485392 | cram | 154.3 MB | Report |
|
| 10 Files (2.3 GB) | ||||